New ATLAS-seq Technology Revolutionizes Identification of Antigen-Reactive T Cells for Cancer Immunotherapy
Researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania developed a new screening technology, Aptamer-based T Lymphocyte Activity Screening and SEQuencing...
Read moreDetails